Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cells
- 14 December 2001
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 63 (2), 207-215
- https://doi.org/10.1016/s0006-2952(01)00844-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Retinoic Acid Receptors α and γ Mediate the Induction of “Tissue” Transglutaminase Activity and Apoptosis in Human Neuroblastoma CellsExperimental Cell Research, 1997
- Apoptosis of N-Type Neuroblastoma Cells After Differentiation With 9-cis-Retinoic Acid and Subsequent WashoutJNCI Journal of the National Cancer Institute, 1997
- Pharmacokinetic studies of 13- cis -retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantationCancer Chemotherapy and Pharmacology, 1996
- Simultaneous determination of all-trans-, 13-cis- and 9-cis-retinoic acid, their 4-oxo metabolites and all-trans-retinol in human plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specificationNature, 1993
- Ligand binding properties of human cellular retinoic acid binding protein II expressed inE. colias a glutathione‐S‐transferase fusion proteinFEBS Letters, 1993
- Phenotype-specific “tissue” transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: Correlation with cell death by apoptosisInternational Journal of Cancer, 1992
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990
- Identification of a second human retinoic acid receptorNature, 1988